https://sab.bio/news/ 2026-11-09T13:30:27+00:00 https://sab.bio/2014/06/23/game-changing-technology-nears-clinical-stage/ 2014-06-24T02:13:40+00:00 https://sab.bio/2014/09/16/animal-biotech-industry-thrives-in-states-climate/ 2014-09-17T04:00:00+00:00 https://sab.bio/wp-content/uploads/2020/02/SAb_NEWS-IMAGES_testing.jpg https://sab.bio/2014/11/26/cows-with-human-chromosomes-enlist-to-fight-hantavirus/ 2014-11-26T20:00:00+00:00 https://sab.bio/wp-content/uploads/2020/02/sn-hantavirus.jpg https://sab.bio/2014/11/26/gmo-cattle-produce-serum-to-fight-hantavirus-is-ebola-next/ 2014-11-26T21:43:00+00:00 https://sab.bio/wp-content/uploads/2020/02/Screen-Shot-2020-02-17-at-8.54.33-PM.png https://sab.bio/2014/11/26/human-antibodies-produced-in-dna-vaccinated-cows-protect-in-lethal-models-of-hantavirus-pulmonary-syndrome/ 2014-11-27T02:26:00+00:00 https://sab.bio/wp-content/uploads/2014/11/SAb_NEWS-IMAGES_watercolor-1.jpg https://sab.bio/2014/11/26/human-antibodies-produced-in-dna-vaccinated-cows-protect-in-lethal-models-of-hantavirus/ 2014-11-27T02:59:00+00:00 https://sab.bio/wp-content/uploads/2020/02/SAb_NEWS-IMAGES_packaging-1.jpg https://sab.bio/2014/11/28/sab-biotherapeutics-inc-producing-human-antibodies-to-combat-disease/ 2014-11-29T01:12:00+00:00 https://sab.bio/2014/12/03/sab-biotherapeutics-and-u-s-army-team-up-to-treat-hantavirus/ 2014-12-03T23:41:00+00:00 https://sab.bio/wp-content/uploads/2014/12/usamriid-use-this.png https://sab.bio/2015/01/06/development-foundation-invests-in-growing-sab-biotherapeutics/ 2015-01-06T21:21:00+00:00 https://sab.bio/wp-content/uploads/2015/01/business.jpg https://sab.bio/2015/09/04/biotech-company-might-help-saudi-arabia-with-mers/ 2015-09-04T13:03:00+00:00 https://sab.bio/wp-content/uploads/2020/02/greenthings.png https://sab.bio/2016/01/19/internationally-recognized-experts-appointed-to-sab-biotherapeutics-scientific-advisory-board/ 2016-01-19T15:32:00+00:00 https://sab.bio/2016/02/17/sab-biotherapeutics-produces-new-human-antibody-treatment-for-mers-cov/ 2016-02-17T20:00:00+00:00 https://sab.bio/wp-content/uploads/2016/02/SAB_MERS_CoV_Vial_Right.jpg https://sab.bio/2016/02/17/new-study-by-university-of-maryland-school-of-medicine-researchers-finds-promising-results-for-treatment/ 2016-02-18T02:12:00+00:00 https://sab.bio/wp-content/uploads/2016/02/maryland.png https://sab.bio/2016/08/11/phase-i-clinical-trials-underway-for-first-mers-treatment/ 2016-08-11T21:24:00+00:00 https://sab.bio/2016/08/24/sab-biotherapeutics-announces-contract-with-barda-to-advance-first-mers-treatment/ 2016-08-24T21:04:58+00:00 https://sab.bio/wp-content/uploads/2016/08/SAB_MERS_CoV_Group_3.jpg https://sab.bio/2016/09/07/sab-biotherapeutics-receives-1-42-million-sbir-grant-to-advance-influenza-treatment/ 2016-09-07T21:02:07+00:00 https://sab.bio/2016/09/20/sab-biotherapeutics-immunotherapy-proposal-among-top-platform-technology-solutions-in-recent-who-report/ 2016-09-20T20:59:36+00:00 https://sab.bio/wp-content/uploads/2016/09/who2.jpg https://sab.bio/2016/10/02/human-antibodies-produced-in-cows-might-help-fight-infectious-diseases/ 2016-10-02T16:00:00+00:00 https://sab.bio/wp-content/uploads/2020/02/Screen-Shot-2020-02-17-at-8.40.27-PM.png https://sab.bio/2016/10/04/cows-engineered-with-human-genes-could-stop-our-next-disease-outbreak/ 2016-10-05T01:41:37+00:00 https://sab.bio/wp-content/uploads/2016/10/MIT2.png https://sab.bio/2017/04/25/sab-biotherapeutics-names-christoph-bausch-as-chief-science-officer/ 2017-04-25T20:57:23+00:00 https://sab.bio/wp-content/uploads/2017/04/CLB.jpg https://sab.bio/2017/04/26/sab-biotherapeutics-strengthens-board-of-directors-with-appointment-of-biotech-veteran/ 2017-04-26T20:53:59+00:00 https://sab.bio/wp-content/uploads/2020/02/Thorkil_Kastberg_Christensen_provided_photo.jpg https://sab.bio/2017/08/03/pharmaceutical-entrepreneur-william-j-polvino-m-d-joins-sab-biotherapeutics-business-advisory-board/ 2017-08-03T20:47:44+00:00 https://sab.bio/wp-content/uploads/2017/08/William_J_Polvino_MD-scaled-1.jpg https://sab.bio/2017/08/30/sab-biotherapeutics-integrates-operations-with-new-production-facility/ 2017-08-30T20:41:45+00:00 https://sab.bio/wp-content/uploads/2017/08/dirt.png https://sab.bio/2017/10/05/post-13/ 2017-10-05T15:32:58+00:00 https://sab.bio/wp-content/uploads/2020/02/future-modeling.jpg https://sab.bio/2017/10/11/heres-whats-next-for-massive-biotech-project/ 2017-10-11T13:00:38+00:00 https://sab.bio/wp-content/uploads/2020/02/SAB_Pharm_Groundbreaking__Group_10_5_17-e1507725135498-1024x513-1.jpg https://sab.bio/2017/12/20/post-12/ 2017-12-20T16:33:00+00:00 https://sab.bio/wp-content/uploads/2018/02/capra.jpg https://sab.bio/2017/12/21/post-11/ 2017-12-21T16:33:24+00:00 https://sab.bio/wp-content/uploads/2020/02/antibodies.png https://sab.bio/2018/01/10/post-10/ 2018-01-10T21:49:00+00:00 https://sab.bio/wp-content/uploads/2020/02/greenthings.png https://sab.bio/2018/02/01/post-9/ 2018-02-01T21:44:00+00:00 https://sab.bio/wp-content/uploads/2018/02/capra.jpg https://sab.bio/2018/05/15/post-8/ 2018-05-15T15:33:52+00:00 https://sab.bio/wp-content/uploads/2018/05/SAB_Molly_Bobbitt_VAC.jpg https://sab.bio/2018/06/04/post-7/ 2018-06-04T15:34:02+00:00 https://sab.bio/wp-content/uploads/2020/02/betterimage.jpg https://sab.bio/2018/08/15/post-5/ 2018-08-15T15:34:19+00:00 https://sab.bio/wp-content/uploads/2018/08/SAB_Biotherapeutics_Antibody-Therapeutic_Ebola-1-scaled-1.jpg https://sab.bio/2018/11/20/post-1/ 2018-11-20T14:00:53+00:00 https://sab.bio/wp-content/uploads/2018/11/Picture1.png https://sab.bio/2018/12/18/post-4/ 2018-12-18T16:34:30+00:00 https://sab.bio/wp-content/uploads/2018/12/cd281890-040a-4fdc-bc29-d0a2b90b1be0-DuvDWF2VYAA1PtJ.jpg https://sab.bio/2018/12/19/s-d-equity-partners-makes-1m-investment-in-sab/ 2018-12-19T14:00:00+00:00 https://sab.bio/wp-content/uploads/2020/02/Screen-Shot-2018-10-29-at-2.17.57-PM-1024x681-850x425-1.png https://sab.bio/2018/12/20/post-3/ 2018-12-20T14:00:37+00:00 https://sab.bio/2019/11/12/sab-adds-to-executive-team-with-industry-veteran/ 2019-11-12T14:00:50+00:00 https://sab.bio/wp-content/uploads/2020/02/Rick-850x425-1.jpg https://sab.bio/2019/12/13/south-dakota-leads-the-future-of-fighting-disease/ 2019-12-13T14:00:17+00:00 https://sab.bio/wp-content/uploads/2019/12/Screen-Shot-2020-03-04-at-3.58.40-PM.png https://sab.bio/2020/01/07/post-2/ 2020-01-07T14:00:00+00:00 https://sab.bio/wp-content/uploads/2020/01/CSL-WHITE-SPACE.png https://sab.bio/2020/02/18/personal-impact-global-influence-right-here-in-south-dakota/ 2020-02-18T14:00:08+00:00 https://sab.bio/wp-content/uploads/2020/02/Screen-Shot-2020-02-19-at-3.13.48-PM.png https://sab.bio/2020/03/12/sioux-falls-biotech-firm-rushing-to-develop-coronavirus-treatment/ 2020-03-12T13:35:39+00:00 https://sab.bio/wp-content/uploads/2020/03/coronavirus-microscopic-1024x581-1.jpg https://sab.bio/2020/03/13/sab-biotherapeutics-delays-development-at-usd-discovery-district/ 2020-03-13T13:00:26+00:00 https://sab.bio/wp-content/uploads/2020/03/Screen-Shot-2020-03-30-at-3.46.10-PM.png https://sab.bio/2020/03/31/sab-biotherapeutics-awarded-27m-contract-to-develop-novel-rapid-response-capability-for-u-s-department-of-defense/ 2020-03-31T14:00:00+00:00 https://sab.bio/wp-content/uploads/2020/04/SAB_Logo_cGMP_Suite_W_J-scaled-1.jpg https://sab.bio/2020/04/02/barda-department-of-defense-and-sab-biotherapeutics-to-partner-to-develop-a-novel-covid-19-therapeutic/ 2020-04-02T13:49:00+00:00 https://sab.bio/wp-content/uploads/2020/04/april-2-2020.png https://sab.bio/2020/04/08/csl-behring-and-sab-biotherapeutics-join-forces-to-deliver-new-potential-covid-19-therapeutic/ 2020-04-08T13:00:00+00:00 https://sab.bio/wp-content/uploads/2020/01/CSL-WHITE-SPACE.png https://sab.bio/2020/04/13/hhs-facilitates-development-of-immunotherapies-for-covid-19-patients/ 2020-04-13T13:40:45+00:00 https://sab.bio/wp-content/uploads/2020/04/Screen-Shot-2020-04-15-at-8.46.17-AM.png https://sab.bio/2020/04/16/sab-biotherapeutics-advances-therapeutic-for-covid-19-in-partnership-with-department-of-defense-and-barda/ 2020-04-16T13:00:00+00:00 https://sab.bio/wp-content/uploads/2020/04/Screen-Shot-2020-04-16-at-1.10.34-PM.png https://sab.bio/2020/04/24/behind-sabs-rapid-response-to-covid-19/ 2020-04-24T13:35:00+00:00 https://sab.bio/wp-content/uploads/2020/04/GenBanner_Coronavirus_World_i.jpg https://sab.bio/2020/04/26/jodis-journal-the-little-biotech-company-that-could-beat-covid-19/ 2020-04-26T13:41:00+00:00 https://sab.bio/wp-content/uploads/2020/04/SAB_Logo_cGMP_Suite_W_J-scaled-1.jpg https://sab.bio/2020/05/01/convalescent-serum-lines-up-as-first-choice-treatment-for-coronavirus/ 2020-05-01T16:30:00+00:00 https://sab.bio/wp-content/uploads/2020/05/d41587-020-00011-1_17947354.jpg https://sab.bio/2020/05/07/i-am-bio-promotion-kit-for-advocates/ 2020-05-07T13:00:00+00:00 https://sab.bio/wp-content/uploads/2019/02/Screen-Shot-2020-05-15-at-1.21.13-PM.png https://sab.bio/2020/05/20/researchers-use-cows-to-develop-antibody-treatment/ 2020-05-20T16:18:07+00:00 https://sab.bio/wp-content/uploads/2020/05/Screen-Shot-2020-05-21-at-11.22.02-AM.png https://sab.bio/2020/05/28/sab-biotherapeutics-confirms-neutralizing-antibodies-to-sars-cov-2-and-begins-clinical-manufacturing-of-novel-covid-19-therapeutic-candidate/ 2020-05-28T13:00:00+00:00 https://sab.bio/wp-content/uploads/2020/05/SAB_cGMP_March_2020_J-scaled-1.jpg https://sab.bio/2020/06/05/this-cows-antibodies-could-be-the-newest-weapon-against-covid-19/ 2020-06-05T21:35:00+00:00 https://sab.bio/wp-content/uploads/2020/06/cow_1280p.jpg https://sab.bio/2020/06/08/sab-biotherapeutics-president-and-ceo-eddie-j-sullivan-phd-featured-on-covid-19-panel-at-bio-digital-2020/ 2020-06-08T13:18:00+00:00 https://sab.bio/wp-content/uploads/2020/06/Screen-Shot-2020-06-08-at-9.00.25-AM.png https://sab.bio/2020/06/16/human-trials-expected-to-start-next-month-for-covid-19-treatment-derived-from-cows-blood/ 2020-06-17T03:41:00+00:00 https://sab.bio/wp-content/uploads/2020/03/coronavirus-microscopic-1024x581-1.jpg https://sab.bio/2020/06/17/cows-help-with-covid-19-treatment-no-bull/ 2020-06-17T10:00:00+00:00 https://sab.bio/2020/07/17/sab-biotherapeutics-closes-series-b-funding/ 2020-07-17T16:18:00+00:00 https://sab.bio/2020/07/30/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-176-for-seasonal-influenza/ 2020-07-30T12:48:00+00:00 https://sab.bio/wp-content/uploads/2020/07/Influenza-Water-Color.png https://sab.bio/2020/08/06/sab-biotherapeutics-awarded-35-6m-from-u-s-department-of-defense-for-covid-19-and-scaling-rapid-response-antibody-program/ 2020-08-06T12:23:00+00:00 https://sab.bio/2020/08/11/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-185-for-the-treatment-and-prevention-of-covid-19/ 2020-08-11T12:41:00+00:00 https://sab.bio/2020/08/21/sab-biotherapeutics-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-sab-185-for-the-treatment-of-covid-19/ 2020-08-21T13:37:00+00:00 https://sab.bio/2020/11/30/sab-biotherapeutics-awarded-57-5m-from-barda-and-u-s-department-of-defense-for-manufacturing-of-sab-185-for-the-treatment-of-covid-19/ 2020-11-30T16:06:53+00:00 https://sab.bio/2020/12/15/sab-biotherapeutics-announces-new-appointments-to-its-board-of-directors/ 2020-12-16T01:19:32+00:00 https://sab.bio/2021/03/04/sab-biotherapeutics-to-present-at-upcoming-march-investor-conferences/ 2021-03-04T23:24:31+00:00 https://sab.bio/2021/04/13/sab-biotherapeutics-strengthens-senior-management-team-with-appointment-of-kipp-erickson-phd-as-chief-operating-officer/ 2021-04-13T15:16:10+00:00 https://sab.bio/wp-content/uploads/2021/04/Screen-Shot-2021-04-13-at-10.55.43-AM.png https://sab.bio/2021/04/21/sab-biotherapeutics-doses-first-patient-with-sab-185-for-the-treatment-of-covid-19-in-nihs-activ-2-phase-2-3-clinical-trial/ 2021-04-21T19:49:27+00:00 https://sab.bio/wp-content/uploads/2021/04/ACTIV-2-SAB-statement-image.jpg https://sab.bio/2021/05/14/sab-biotherapeutics-to-present-at-rbc-capital-markets-2021-global-healthcare-conference/ 2021-05-14T16:05:23+00:00 https://sab.bio/2021/06/10/sab-biotherapeutics-appoints-carlos-carrillo-phd-as-senior-vice-president-regulatory-affairs/ 2021-06-10T14:57:46+00:00 https://sab.bio/wp-content/uploads/2021/06/Screen-Shot-2021-06-10-at-9.56.32-AM.png https://sab.bio/2021/06/14/sab-biotherapeutics-to-participate-in-expert-panel-at-bio-digital-2021/ 2021-06-14T15:03:43+00:00 https://sab.bio/wp-content/uploads/2021/06/pressreleasephoto061421.jpg https://sab.bio/2021/06/22/sab-biotherapeutics-merger/ 2021-06-22T11:20:12+00:00 https://sab.bio/wp-content/uploads/2021/06/SocialMediaPost_FINAL-scaled-1.jpg https://sab.bio/2021/06/29/sab-biotherapeutics-doses-first-participant-in-phase-2a-trial-of-sab-176-for-the-treatment-of-influenza/ 2021-06-29T14:00:16+00:00 https://sab.bio/wp-content/uploads/2021/06/Influenza-Water-Color.png https://sab.bio/2021/07/07/big-cypress-acquisition-corp-announces-confidential-submission-of-s-4-registration-statement-related-to-proposed-business-combination-with-sab-biotherapeutics/ 2021-07-07T11:00:00+00:00 https://sab.bio/wp-content/uploads/2021/06/SocialMediaPost_FINAL-scaled-1.jpg https://sab.bio/2021/07/08/sab-biotherapeutics-announces-publication-of-preclinical-data-demonstrating-sab-185-effectively-neutralizes-sars-cov-2-variants/ 2021-07-08T14:17:50+00:00 https://sab.bio/wp-content/uploads/2021/07/HVI.jpg https://sab.bio/2021/07/09/sab-biotherapeutics-to-present-at-the-ladenburg-thalmann-annual-healthcare-conference-2021/ 2021-07-09T12:37:18+00:00 https://sab.bio/wp-content/uploads/2021/07/image001-30.png https://sab.bio/2021/08/11/sab-biotherapeutics-announces-nonclinical-data-demonstrating-sab-185-potently-neutralizes-delta-and-lambda-sars-cov-2-variants/ 2021-08-11T11:25:12+00:00 https://sab.bio/wp-content/uploads/2021/08/biorxiv.jpg https://sab.bio/2021/09/08/sab-biotherapeutics-to-present-at-upcoming-september-virtual-investor-conferences/ 2021-09-08T11:17:26+00:00 https://sab.bio/wp-content/uploads/2021/07/image001-30.png https://sab.bio/2021/09/15/sab-biotherapeutics-announces-completion-of-enrollment-in-phase-2a-challenge-trial-of-sab-176-for-the-treatment-of-seasonal-influenza/ 2021-09-15T12:19:08+00:00 https://sab.bio/wp-content/uploads/2021/06/Influenza-Water-Color.png https://sab.bio/2021/09/22/sab-biotherapeutics-awarded-additional-60-5m-from-barda-and-u-s-department-of-defense-for-rapid-response-capability-and-advancing-sab-185-for-treatment-of-covid-19/ 2021-09-22T11:31:28+00:00 https://sab.bio/wp-content/uploads/2021/07/image001-30.png https://sab.bio/2021/09/23/big-cypress-acquisition-corp-announces-special-meeting-of-stockholders-to-approve-business-combination-with-sab-biotherapeutics/ 2021-09-23T16:09:10+00:00 https://sab.bio/wp-content/uploads/2021/09/bigcypresssab.jpg https://sab.bio/2021/09/24/sab-biotherapeutics-announces-sab-185-receives-positive-dsmb-review-and-advances-to-phase-3-in-nih-sponsored-activ-2-trial-for-treatment-of-covid-19/ 2021-09-24T11:10:37+00:00 https://sab.bio/wp-content/uploads/2021/09/SocialMediaPost092221k.jpg https://sab.bio/2021/09/28/sab-biotherapeutics-appoints-russell-beyer-chief-financial-officer/ 2021-09-28T11:08:33+00:00 https://sab.bio/wp-content/uploads/2021/09/RussellBeyerPhotorev2.jpg https://sab.bio/2021/10/04/sab-biotherapeutics-announces-first-patient-dosed-in-phase-3-nih-activ-2-trial-evaluating-sab-185-for-treatment-of-covid-19/ 2021-10-04T11:30:37+00:00 https://sab.bio/wp-content/uploads/2021/09/SocialMediaPost092221k.jpg https://sab.bio/2021/10/06/sab-biotherapeutics-to-host-virtual-rd-day-on-october-13-2021/ 2021-10-06T12:08:22+00:00 https://sab.bio/2021/10/13/introduction-to-sabs-unique-diversitab-immunotherapy-platform/ 2021-10-14T02:30:07+00:00 https://sab.bio/wp-content/uploads/2021/10/RDDayInviteRev16.jpg